Markets.com Logo

YMAB

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    8.6034$
  • Previous Close
    8.6005$
  • 52 Week Change
    12.56$
  • Day Range
    0.00$
  • 52 Week High/Low
    3.55$ - 16.11$
  • Dividend Per Share
    --
  • Market cap
    388 M$
  • EPS
    -0.07
  • Beta
    0.564
  • Volume
    --

About

YMAB.US represents Yumanity Therapeutics, Inc., a biopharmaceutical company focused on developing innovative therapies for neurodegenerative diseases. Specifically, Yumanity was working on treatments targeting protein misfolding, a common characteristic in conditions like Parkinson's disease, Lewy body dementia, and amyotrophic lateral sclerosis (ALS). However, the company experienced setbacks in its clinical trials, ultimately leading to the discontinuation of its lead program and a strategic shift towards exploring other opportunities, including a merger.
XLM Stellar Price Prediction: How High Can XLM/USD Go in 2026?

XLM Stellar Price Prediction: How High Can XLM/USD Go in 2026?

Ghko B|--
Investment for beginners 2026: Is now a good time to buy Vanguard S&P 500 ETF?

Investment for beginners 2026: Is now a good time to buy Vanguard S&P 500 ETF?

Ghko B|--
NIO stock is trading down today: What’s happening with Nio Inc?

NIO stock is trading down today: What’s happening with Nio Inc?

Frances Wang|--
Nvidia Stock Analysis: Is now a good time to buy the dip in NVDA stock?

Nvidia Stock Analysis: Is now a good time to buy the dip in NVDA stock?

Ghko B|--
Tata Gold analysis: How does Tata Gold ETF compare to Tata Gold share?

Tata Gold analysis: How does Tata Gold ETF compare to Tata Gold share?

Ghko B|--
Bitcoin price forecast: Bitcoin falls below $70K, will BTC continue to slide?

Bitcoin price forecast: Bitcoin falls below $70K, will BTC continue to slide?

Frances Wang|--
Ethereum price analysis: What’s the price prediction for ETH/USD 2026?

Ethereum price analysis: What’s the price prediction for ETH/USD 2026?

Ghko B|--

Factors

No title. Drug Development Progress: Clinical trial results, regulatory approvals, and pipeline advancements directly impact investor confidence and YMAB.US stock price.

Market Sentiment: Overall market conditions, industry trends (biotech, antibody therapeutics), and investor risk appetite influence demand for YMAB.US shares.

Financial Performance: Revenue, earnings, profitability, cash flow, and debt levels influence investor valuation and the stock's perceived worth.

Competition: Competing products, new entrants, and technological advancements in the antibody therapeutics market can affect YMAB.US's market share and stock price.

Partnerships and Collaborations: Strategic alliances, licensing agreements, and collaborations can signal growth potential and boost investor confidence in YMAB.US.

Economic Factors: Economic growth, interest rates, inflation, and currency exchange rates can indirectly influence investment decisions and YMAB.US's stock valuation.

Company News and Events: Press releases, earnings announcements, investor presentations, and significant corporate developments affect investor sentiment and trading activity.

Regulatory Environment: Changes in regulations related to drug development, approval processes, and healthcare policies can impact YMAB.US's operations and stock price.

Management Team: The experience, expertise, and strategic vision of YMAB.US's leadership team can influence investor confidence and the company's performance.

Analyst Ratings: Recommendations and price targets from financial analysts can affect investor perception and trading activity, impacting YMAB.US's stock price.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--
Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--
Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

How to invest in gold in 2026: A beginner's guide to gold CFDs

How to invest in gold in 2026: A beginner's guide to gold CFDs

Ghko B|--
CFD Trading for Beginners: What to Know about Online Markets & Trading Platforms?

CFD Trading for Beginners: What to Know about Online Markets & Trading Platforms?

Georgy Istigechev|--
CFD trading basics: Long position VS. short position, which is better?

CFD trading basics: Long position VS. short position, which is better?

Ghko B|--